This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Naloxone may be beneficial in the treatment of tardive dyskinesia.Clin Neuropharmacol. 1984; 7: 265-267
- Secretion patterns of endogenous opioids in chronic schizophrenia.Am J Psychiatry. 1984; 141: 1183-1189
- Central distribution of opioid peptides.Br Med Bull. 1983; 39: 11-16
- Evidence for underactivity of the opioid system in neuroleptic-induced akathisia.Psychiatry Res. 1984; 13: 187
- Brain catecholamines in schizophrenia: A good case for noradrenaline.Nature. 1982; 299: 484-486
- Noradrenaline and tardive dyskinesia.Br J Psychiatry. 1984; 145: 217
Article info
Identification
Copyright
© 1985 Published by Elsevier Inc.
